Over 75 anti-LGBTQ+ legislative bills signed in 2023 have placed transgender youths and adults at risk.
Trans motherhood showcases joys of being transgender, be it through developing a deeper connection with one’s own child or caring for others in one’s community.
Even when outdated misconceptions about race are removed from clinical guidelines, gaps in care remain for patients of color.
Expert outlines strategies for providing culturally competent care that respects the unique needs and experiences of LGBTQ+ patients.
Recent FDA approvals include treatments for chronic migraine, type 1 diabetes, blood cancers, tardive dyskinesia and chorea associated with Huntington disease, vasomotor symptoms of menopause, pain and fever, and Fabry disease.
March FDA approvals include treatments for candidemia and invasive candidiasis, sleep apnea for children with Down syndrome, pediatric BRAF V600E low-grade glioma, and migraines.
February FDA approvals include treatments for geographic atrophy, proteinuria, tardive dyskinesia and chorea associated with Huntington disease, and anemia.
Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.
Health awareness campaigns occur all throughout the year in a wide variety of medical fields. These are when health awareness days, weeks, and months are happening this year.
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.